Status:
TERMINATED
A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia
Lead Sponsor:
University of Medicine and Dentistry of New Jersey
Conditions:
Oral Leukoplakia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
You have been asked to participate in this research study because you have or may have oral leukoplakia. Oral leukoplakia is described as a white patch or plaque on the oral mucosa (mouth) that will n...
Detailed Description
Since oral leukoplakia may precede the development of cancer, using agents that may prevent cancer, called chemoprevention, may be useful. The purpose of this study is to determine whether taking a gr...
Eligibility Criteria
Inclusion
- Patients with oral leukoplakia without evidence of active infections in the mouth will be invited to participate in this study.
- Patients must currently consume no more than 3 cups of tea a day,
- not be taking large doses of vitamin A or its derivatives (more than 25,000 units), selenium, or beta-carotene.
- Additionally, patients must not participate in this study if they are allergic to caffeine, have GI ulcers, are pregnant, or have had previous invasive mouth cancer.
Exclusion
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2006
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00176566
Start Date
September 1 2003
End Date
November 1 2006
Last Update
December 11 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Cancer Institute of New Jersey
New Brunswick, New Jersey, United States, 08901